Bioengineering Partnerships with Industry (BPI)

Bioengineering Partnerships with Industry (BPI) sits under the National Institute of Biomedical Imaging and Bioengineering at NIH and is built for academic-industry teams developing biomedical technologies on a 5- to 10-year path to implementation. The program is organized around unmet biomedical needs, joint leadership, and specific milestones that can be tracked over time. BPI uses the U01 cooperative agreement mechanism and supports up to $600,000 a year in direct costs for as long as five years, or about $3 million in total direct costs. Projects that ask for more than $500,000 in annual direct costs need a white paper and written approval from NIBIB staff at least six weeks before the deadline. The active NOFO is PAR-24-325, and receipt dates run through 2025 to 2027 under the standard NIH U01 schedule. The program fits teams that can show a real division of labor between academic and industrial partners and deliver measurable progress toward a biomedical product or platform. Because NIBIB participates through a cooperative agreement, applicants need more than a paper alliance: the work has to be structured for milestone review, clear accountability, and a credible route from development to translation.

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.